MEK1/2 inhibitor withdrawal reverses acquired resistance driven by BRAFV600E amplification whereas KRASG13D amplification promotes EMT-chemoresistance
- Resource Type
- article
- Source
- Nature Communications, Vol 10, Iss 1, Pp 1-22 (2019)
- Subject
Science - Language
- English
- ISSN
- 2041-1723